Aegon 2024 results show operating capital generation of €1.3bn

On an IFRS basis, the full‑year operating result was €1.5bn, providing an earnings backdrop that is broadly aligned with the capital generation narrative. In the second half alone, the operating result improved 14% year‑on‑year to €776m, while net profit reached €741m, indicating that earnings quality has been sufficient to support both capital generation and cash.

Capital return and balance sheet stance

The 2024 final dividend proposal of €0.19 per common share represents a 19% increase on the prior year’s final dividend, signalling growing confidence in the sustainability of cash flows. This sits alongside a stated ambition to grow dividend per share to around €0.40 over 2025, effectively pre‑committing a higher payout trajectory that will need to be underpinned by continued capital generation and disciplined risk selection.

Share buybacks have become a core component of Aegon’s capital management toolkit. The group completed a €1.535bn buyback in June, followed by a further €200m buyback in December. It also announced a new €150m buyback in the third quarter, expected to complete in the first half of 2025, and has already started this programme in January 2025. For investors in insurance equity and hybrid capital, this pattern of recurring buybacks, layered on top of a rising ordinary dividend, reinforces the perception of a structurally cash‑generative, capital‑light group.

At the same time, gross financial leverage is expected to remain around €5bn, suggesting that management is comfortable with the current debt stack and is prioritising distributions over rapid de‑leveraging. For credit investors and regulators, the message is that balance sheet optimisation will be incremental and funded by ongoing capital generation rather than by shrinking the liability side. Valuation equity per share, Aegon’s internal measure of shareholder value, increased 12% to €8.91 in 2024, indicating that the combination of capital return and business mix shift is also accretive on a value basis. That metric will be closely watched by boards and CIOs as a gauge of whether continued buybacks remain value‑creative versus alternative uses of capital. Business mix: asset management and international life

Aegon Asset Management delivered around €14bn of third‑party net deposits across its Global Platforms and Strategic Partnerships in 2024. For insurance allocators, this shows Aegon AM’s positioning as a scale player in outsourced mandates, with growing fee income that does not consume group capital and can support holding‑level cash flows. In the International business, new life sales fell 15%, mainly due to pricing actions in China to reflect lower interest rates. However, value of new business in the same segment grew 18%, driven by Brazil and Spain & Portugal, highlighting a deliberate pivot toward higher‑margin, more capital‑efficient products and geographies. For peers, this is a clear case study in trading volume for value when the rate environment and capital framework make legacy guarantees unattractive. Outlook

The key constraint now is execution: sustaining roughly €1.2bn of operating capital generation while maintaining €5bn of gross leverage and delivering the targeted step‑up in dividends and buybacks. For insurance CIOs, the next decision point will be whether Aegon can keep compounding valuation equity per share while running a shareholder‑yield‑heavy capital policy through the next rate and credit cycle.

Sources: aegon.com · aegon.com